BioSpace News Archive

Akorn, Inc., a leading specialty pharmaceutical company, announced its financial results for the quarter and year ended December 31, 2019.

The following quote is attributed to Frank Yiannas, Deputy Commissioner for Food Policy and Response

Westinghouse Electric Company and Nordion Inc., a Sotera Health Company, announced they have signed a Letter of Intent to develop innovative isotope production technology that will allow Cobalt-60 to be produced in Pressurized Water Reactors.

AHF asks FTC and DOJ to strengthen Draft 2020 Vertical Merger Guidelines.

REGENXBIO Inc., a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV Technology Platform, announced financial results for the fourth quarter and full year ended December 31, 2019, and recent operational highlights.

Exelixis, Inc. announced that members of Exelixis’ management team will provide a corporate overview at the following investor conferences in March

RECOVER sub-study will leverage Verily research tools to provide quantitative assessment measures of depressive episodes

ERYTECH Pharma announced that Gil Beyen, Chief Executive Officer, will present a corporate update at the Cowen and Company 40th Annual Health Care Conference on March 2, 2020 in Boston, MA.

Voyager Therapeutics, Inc., a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, will webcast management presentations as follows

Mesoblast Limited reported financial, corporate and operational highlights for the half year ended December 31, 2019.